Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Research & Development (2020 - 2025)

INVO Fertility (IVF) has disclosed Research & Development for 7 consecutive years, with $127807.0 as the latest value for Q2 2025.

  • Quarterly Research & Development changed N/A to $127807.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $777120.0 through Sep 2025, up 7104.23% year-over-year, with the annual reading at $388530.0 for FY2024, 134.13% up from the prior year.
  • Research & Development for Q2 2025 was $127807.0 at INVO Fertility, down from $265663.0 in the prior quarter.
  • The five-year high for Research & Development was $383650.0 in Q4 2024, with the low at $2668.0 in Q3 2023.
  • Average Research & Development over 5 years is $106776.1, with a median of $73677.5 recorded in 2022.
  • The sharpest move saw Research & Development crashed 98.48% in 2023, then surged 6394.84% in 2024.
  • Over 5 years, Research & Development stood at $63756.0 in 2021, then rose by 15.81% to $73835.0 in 2022, then tumbled by 92.0% to $5907.0 in 2023, then soared by 6394.84% to $383650.0 in 2024, then tumbled by 66.69% to $127807.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $127807.0, $265663.0, and $383650.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.